CLINICAL_TRIALS
trial_result
· 2023-07-03
Clinical Trial Update: Optilume™ BPH Prostatic Drug Coated Balloon Dilation Catheter [Phase 2]
Summary
Phase 2 results update for Optilume, a drug-coated balloon dilation catheter used to treat benign prostatic hyperplasia (BPH).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Urotronic Inc. | Conditions: Benign Prostatic Hyperplasia, Benign Prostatic Hypertrophy | Phase 2 | Status: COMPLETED | Results posted: 2023-07-03